跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPTI-TEARS RED EYE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OPTI-TEARS RED EYE
Authorized
STANDARD
OPTI-TEARS RED EYE
Alcon Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
63ace4f7b78cd4ee
Company
Alcon Canada Inc
Type
Standard
Approval Details
Approval Id
63ace4f7b78cd4ee
Drug Approval Canada Name
OPTI-TEARS RED EYE
Product Name
OPTI-TEARS RED EYE
Status
Cancelled Post Market
Status Date
2024-02-22
Original Market Date
2017-04-04
Din
02449609
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
52:32.00
Atc Original
S01GA01 NAPHAZOLINE
Atc Name
s 01 ga 01
Aig Number
0103282001
Company Name
Alcon Canada Inc
Company Address
2665 Meadowpine Blvd, Mississauga, Ontario, Canada, L5N 8C7
Active Ingredients
NAPHAZOLINE HYDROCHLORIDE
0.1 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
63ace4f7b78cd4ee
Type
Standard
Back to Health Canada Approvals